Gary has 20+ years’ experience working in the biopharmaceutical sector. Since joining Abzena in 2013 Gary has managed business development activities associated with immunological responses to biotherapeutics ensuring that immunogenicity assessment and bespoke immunological studies are tailored to partner’s needs. Prior to this Gary worked at Envigo as a Biopharmaceutical Product Development Manager and shared responsibility for designing safety studies and non-clinical development programmes for all biologics, providing scientific support and advice to the immunology department. Previous roles at GSK’s included Biology Leader investigating the immunogenicity and efficacy of DNA vaccines, molecular adjuvants and anti-inflammatory antagonist mAbs where he co-authored several patents in these fields. Gary completed his PhD from the University of Bristol, Department of Veterinary Medicine.